We are a clinical stage biopharmaceutical company developing peptide-based therapeutics:
- Pemvidutide for obesity
- Pemvidutide for non-alcoholic steatohepatitis (NASH)
- HepTcell™ for chronic hepatitis B
We are a clinical stage biopharmaceutical company developing peptide-based therapeutics: